1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Massachusetts >
  6. MDxHealth Acquires Exosome Diagnostics

M&A Deal Summary

MDxHealth Acquires Exosome Diagnostics

On August 5, 2025, MDxHealth acquired life science company Exosome Diagnostics from Bio-Techne

Acquisition Highlights
  • This is MDxHealth’s 3rd transaction in the Life Science sector.
  • This is MDxHealth’s 2nd transaction in the United States.
  • This is MDxHealth’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2025-08-05
Target Exosome Diagnostics
Sector Life Science
Buyer(s) MDxHealth
Sellers(s) Bio-Techne
Deal Type Divestiture

Target

Exosome Diagnostics

Waltham, Massachusetts, United States
Exosome Diagnostics is a developer and commercializing revolutionary, biofluid-based diagnostics to deliver personalized precision healthcare. Exosome Diagnostics is based in Waltham, Massachusetts.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MDxHealth

Herstal, Belgium
Category Company
Founded 2003
Sector Life Science
Employees300
Revenue 90M USD (2024)
DESCRIPTION

MDxHealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients. MDxHealth was founded in 2003 and is based in Herstal, Belgium.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 3 of 3
Type: Divestiture M&A Deals 2 of 2
State: Massachusetts M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-02 Exact Sciences - DX GPS Prostate Cancer Business

Madison, Wisconsin, United States

Exact Sciences's DX GPS Prostate Cancer Business is a broadly commercialized and clinically validated test available today across the urology community. Exact Sciences's DX GPS Prostate Cancer Business is based in Madison, Wisconsin.

Buy $100M

Seller(S) 1

SELLER

Bio-Techne

Minneapolis, Minnesota, United States
Category Company
Founded 1976
Sector Life Science
Employees3,200
Revenue 1.2B USD (2024)
DESCRIPTION
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.

Bio-Techne is a life sciences company that provides bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. Bio-Techne was founded in 1976 and is based in Minneapolis, Minnesota.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 2 of 2
State: Massachusetts M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-25 Bio-Techne - Fetal Bovine Serum Product Rights

Minneapolis, Minnesota, United States

Bio-Techne's Fetal Bovine Serum (FBS) Product Rights manufactures fetal bovine serum (FBS) product brands.

Sell -
Mergr

Solution for

Product

Company

Legal